Medicare Enrolled

Dr. Heather Reagin, DO

Dermatology · Saginaw, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
616 E BAILEY BOSWELL RD, Saginaw, TX 76131
8175291400
In practice since 2014 (11 years)
NPI: 1407260151 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reagin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reagin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reagin

Dr. Heather Reagin is a dermatology in Saginaw, TX, with 11 years in practice. Based on federal Medicare data, Dr. Reagin performed 1,958 Medicare services across 1,227 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reagin received a total of $14,767 from 44 pharmaceutical and/or device companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reagin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ 1,958 Medicare services$ $14,767 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,958
Medicare services
Bottom 46% in TX for dermatology
1,227
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~178 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14600$5$20
Office visit, established patient (20-29 min)285$63$270
Destruction of precancerous skin growth, 1240$37$203
Skin biopsy, tangential178$68$307
Office visit, established patient (30-39 min)162$91$383
Destruction of skin growths (warts/lesions), 1-14132$82$344
New patient office visit (30-44 min)99$66$335
Office visit, established patient (10-19 min)52$40$170
New patient office visit (45-59 min)46$114$498
New patient office or other outpatient visit, 15-29 minutes32$41$217
Biopsy of related skin growth, each additional growth26$40$152
Destruction of precancer skin growth, 15 or more growths15$106$508
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less14$191$799
Complicated repair of wound of trunk, 2.6-7.5 cm14$309$1,202
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm13$99$740
Administration of chemotherapy into growth, 1-713$44$254
Injection, fluorouracil, 500 mg13$2$10
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm12$321$1,289
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm12$126$539
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,767
Total received (2018-2024)
Avg $2,110/year across 7 years
Top 17% in TX for dermatology
44
Companies
620
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,731 (86.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,650 (11.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$386 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,445
2023
$2,826
2022
$2,885
2021
$751
2020
$498
2019
$1,800
2018
$2,562

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EPI Health, LLC
$1,500
AbbVie, Inc.
$1,313
GENZYME CORPORATION
$1,125
ABBVIE INC.
$1,104
Dermavant Sciences, Inc.
$1,002
Regeneron Healthcare Solutions, Inc.
$995
PFIZER INC.
$658
Arcutis Biotherapeutics, Inc.
$553
Novartis Pharmaceuticals Corporation
$495
Janssen Biotech, Inc.
$464
Celgene Corporation
$443
Sun Pharmaceutical Industries Inc.
$428
E.R. Squibb & Sons, L.L.C.
$427
Galderma Laboratories, L.P.
$385
Ortho Dermatologics, a division of Bausch Health US, LLC
$371
SUN PHARMACEUTICAL INDUSTRIES INC.
$348
Mayne Pharma Inc.
$291
MAYNE PHARMA COMMERCIAL LLC
$257
Incyte Corporation
$254
Janssen Scientific Affairs, LLC
$218
LEO Pharma Inc.
$206
Lilly USA, LLC
$200
Amgen Inc.
$191
Allergan, Inc.
$188
MAYNE PHARMA INC.
$186
COMSORT, Inc
$150
AbbVie Inc.
$126
Journey Medical Corporation
$118
Almirall LLC
$118
Merz North America, Inc.
$92
Glenmark Therapeutics Inc.
$78
Encore Dermatology Inc.
$69
Genentech USA, Inc.
$64
UCB, Inc.
$61
Novum Pharma, LLC
$59
Biofrontera Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
MIMEDX Group, Inc.
$33
DUSA Pharmaceuticals, Inc.
$22
Mission Pharmacal Company
$19
Mylan Pharmaceuticals Inc.
$17
Allergan Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Exeltis, USA Inc.
$12
Top 3 companies account for 26.7% of total payments
Associated products mentioned in payments ›
20% · ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · ARAZLO · Absorica LD · Acticlate · Alcortin A · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPSOLAY · EUCRISA · Ecoza · Enbrel · Erivedge · GARDASIL · HUMIRA · Humira · ILUMYA · Impoyz · JUBLIA · Klisyri · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · NO PRODUCT DISCUSSED · Novacort · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · STELARA · Seysara · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · VTAMA · WYNZORA · Winlevi · Xeomin · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $754 per 100 Medicare services performed
Looking for a dermatology in Saginaw?
Compare dermatologys in the Saginaw area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
83
Per 100K population
3.9
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL ALLIANCE
5.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reagin is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 17%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reagin experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Reagin performed 600 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reagin receive payments from pharmaceutical companies?
Yes. Dr. Reagin received a total of $14,767 from 44 companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reagin's costs compare to other dermatologys in Saginaw?
Dr. Reagin's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reagin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →